← back to search

Ji‐Young Lee

Inserm · FR
Area of research
Epidemiology · Surgery
Research interest
Research interests include Liver Disease Diagnosis and Treatment, Cholesterol and Lipid Metabolism, Adipokines, Inflammation, and Metabolic Diseases, and Liver physiology and pathology.
h-index
49
citations
8,548
works
305
NIH funding
primary concept
email

Recent publications

Comparison of HAV and HCV infections in vivo and in vitro reveals distinct patterns of innate immune evasion and activation
Journal of Hepatology 2023cited by 19position: middledoi
A Hepatitis C virus genotype 1b post-transplant isolate with high replication efficiency in cell culture and its adaptation to infectious virus production in vitro and in vivo
PLoS Pathogens 2022cited by 10position: middledoi
Endosomal egress and intercellular transmission of hepatic ApoE-containing lipoproteins and its exploitation by the hepatitis C virus
bioRxiv (Cold Spring Harbor Laboratory) 2022cited by 2position: middledoi
A Hepatitis C virus genotype 1b post-transplant isolate with high replication efficiency in cell culture and its adaptation to infectious virus production in vitro and in vivo
bioRxiv (Cold Spring Harbor Laboratory) 2022cited by 1position: middledoi
Contribution of autophagy machinery factors to HCV and SARS-CoV-2 replication organelle formation
Cell Reports 2021cited by 103position: middledoi
Convergent use of phosphatidic acid for hepatitis C virus and SARS-CoV-2 replication organelle formation
Nature Communications 2021cited by 84position: middledoi
Convergent use of phosphatidic acid for Hepatitis C virus and SARS-CoV-2 replication organelle formation
bioRxiv (Cold Spring Harbor Laboratory) 2021cited by 9position: middledoi
Spatiotemporal Coupling of the Hepatitis C Virus Replication Cycle by Creating a Lipid Droplet- Proximal Membranous Replication Compartment
Cell Reports 2019cited by 113position: firstdoi
Loss of PDK4 switches the hepatic NF‐κB/TNF pathway from pro‐survival to pro‐apoptosis
Hepatology 2018cited by 93position: middledoi
Secretion of Hepatitis C Virus Replication Intermediates Reduces Activation of Toll-Like Receptor 3 in Hepatocytes
Gastroenterology 2018cited by 82position: middledoi
Mitophagy Controls the Activities of Tumor Suppressor p53 to Regulate Hepatic Cancer Stem Cells
Molecular Cell 2017cited by 249position: middledoi
Maturation of secreted HCV particles by incorporation of secreted ApoE protects from antibodies by enhancing infectivity
Journal of Hepatology 2017cited by 67position: middledoi
Eliciting the mitochondrial unfolded protein response by nicotinamide adenine dinucleotide repletion reverses fatty liver disease in mice
Hepatology 2015cited by 358position: middledoi
Anosmin-1 contributes to brain tumor malignancy through integrin signal pathways
Endocrine Related Cancer 2013cited by 32position: middledoi
Three-Dimensional Architecture and Biogenesis of Membrane Structures Associated with Hepatitis C Virus Replication
PLoS Pathogens 2012cited by 514position: middledoi

Grants

Gene Regulatory Networks in Stem Cells for Root Vascular Tissues
NSF0818071$435,0002008–2012PIRePORTER

Frequent collaborators

Ralf Bartenschlager · German Cancer Research Center9 papers (2012–2023)Uta Haselmann · Heidelberg University6 papers (2019–2022)Volker Lohmann · Heidelberg University5 papers (2018–2023)Cong Si Tran · University Hospital Heidelberg4 papers (2021–2023)Ombretta Colasanti · University Hospital Heidelberg4 papers (2018–2023) · 3 papers (2019–2021)Paul Schnitzler · Heidelberg University3 papers (2018–2022)Vibor Laketa · University Hospital Heidelberg3 papers (2022–2022)Uta Merle · University of Lübeck3 papers (2022–2023) · 3 papers (2022–2023) · 3 papers (2022–2023)Vibhu Prasad · University Hospital Heidelberg2 papers (2021–2021)Christian Ritter · Michigan State University2 papers (2019–2022)Karl Rohr · Heidelberg University2 papers (2019–2022)Young‐Ki Park · University of Connecticut2 papers (2015–2018)Oliver Grünvogel · University Hospital Heidelberg2 papers (2018–2023)Berati Cerikan · University Hospital Heidelberg2 papers (2021–2021) · 2 papers (2021–2022) · 2 papers (2022–2022) · 2 papers (2021–2021)